Efficacy of Fish Oil in Lupus Patients

• Status: Completed
• Trial end date: 2011-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators hypothesize that low-dose dietary supplementation with omega-3 fish oil will improve disease activity and endothelial function in Systemic Lupus Erythematosus (SLE) patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Michelle Petri M.D.,MPH

Criteria

Inclusion Criteria:

• Patients with a clinical diagnosis of SLE are eligible.

• Patients must be 18 years of age or older and able to give informed consent.

Exclusion Criteria:

• SLE patients who are allergic to fish oil or any omega 3 product.

• Patients who are pregnant or are planning to become pregnant or are nursing.

• Omega-3 use within the previous 6 weeks of enrollment.

• Use of warfarin or heparin.

• Patients who have coronary artery disease.